A case in point: it turns out that only about half of the new prescription medications pushed onto the market over the last decade had the proper data together for the U.S. Food and Drug Administration - yet the FDA approved them anyhow.
The researchers found that only about half of 197 eligible approved NMEs between 2000 and 2010 had comparative efficacy data available at the time they were approved to be marketed.
Meanwhile, another recent study throws needed light on the limited data behind the safety and effectiveness of some Big Pharma drugs.
One of the strictest abortion bans in the country will be on the ballot this November...
Martha Lillard, who contracted polio at age five and spent most of her life dependent on...
One in four Israelis now engages in harmful substance use as the psychological fallout from Israel’s...
New York City’s famed Solomon R Guggenheim Museum was among a number of Manhattan buildings that...
